Tubocurarine

Tubocurarine

Clinical data
Routes of administration	I.V.
ATC code	M03AA02 (WHO) M03AA04 (WHO)
Legal status
Legal status	banned
Pharmacokinetic data
Protein binding	50%
Elimination half-life	1-2 Hours
Identifiers
CAS Number	6989-98-6
PubChem CID	6000
DrugBank	APRD00176
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C37H41N2O6
Molar mass	609.731 g/mol

WikiDoc Resources for Tubocurarine
Articles
Most recent articles on Tubocurarine Most cited articles on Tubocurarine Review articles on Tubocurarine Articles on Tubocurarine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tubocurarine Images of Tubocurarine Photos of Tubocurarine Podcasts & MP3s on Tubocurarine Videos on Tubocurarine
Evidence Based Medicine
Cochrane Collaboration on Tubocurarine Bandolier on Tubocurarine TRIP on Tubocurarine
Clinical Trials
Ongoing Trials on Tubocurarine at Clinical Trials.gov Trial results on Tubocurarine Clinical Trials on Tubocurarine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tubocurarine NICE Guidance on Tubocurarine NHS PRODIGY Guidance FDA on Tubocurarine CDC on Tubocurarine
Books
Books on Tubocurarine
News
Tubocurarine in the news Be alerted to news on Tubocurarine News trends on Tubocurarine
Commentary
Blogs on Tubocurarine
Definitions
Definitions of Tubocurarine
Patient Resources / Community
Patient resources on Tubocurarine Discussion groups on Tubocurarine Patient Handouts on Tubocurarine Directions to Hospitals Treating Tubocurarine Risk calculators and risk factors for Tubocurarine
Healthcare Provider Resources
Symptoms of Tubocurarine Causes & Risk Factors for Tubocurarine Diagnostic studies for Tubocurarine Treatment of Tubocurarine
Continuing Medical Education (CME)
CME Programs on Tubocurarine
International
Tubocurarine en Espanol Tubocurarine en Francais
Business
Tubocurarine in the Marketplace Patents on Tubocurarine
Experimental / Informatics
List of terms related to Tubocurarine

Overview

Tubocurarine chloride is a mixed antagonist of nicotinic neuromuscular acetylcholine receptors, used to paralyse patients undergoing anaesthesia. It is one of the chemicals that can be obtained from curare, itself an extract of Chondrodendron tomentosum, a plant found in South American jungles which is used as a source of arrow poison. Native indians hunting animals with this poison were able to eat the animal's contaminated flesh without being affected by the toxin because tubocurarine cannot easily cross mucous membranes and is thus inactive orally.

Medically, first used in 1912. Introduced in anaesthesia in 1942. The correct chemical structure was only elucidated circa 1970, even though the plant had been known since the Spanish Conquest.

The word curare comes from the South American Indian name for the arrow poison: "ourare". Presumably the initial syllable was pronounced with a heavy glottal stroke. Tubocurarine is so called because the plant samples containing it were first shipped to Europe in tubes.

Today, tubocurarine has fallen into disuse in western medicine, as safer synthetic alternatives such as atracurium are available. However, tubocurarine is still used in the United States and elsewhere as part of the lethal injection procedure.

Other names

d-Tubocurarine. Tubocurarin. Tubocurarinum. Delacurarine. Tubarine. Metubine. Jex

HSDB 2152. Isoquinoline Alkaloid. Tubadil. Mecostrin. Intracostin. Intocostrin.